+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

U.S. Hospice Market Size, Share & Trends Analysis Report by Type (Routine Home Care, Continuous Home Care, Inpatient Respite Care), Location (Hospice Center, Home Hospice Care), Diagnosis (Dementia, Cancer) with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 90 Pages
  • February 2025
  • Region: United States
  • Grand View Research
  • ID: 5561846
The U.S. Hospice Market was valued at USD 29.92 billion in 2024, and is projected to reach USD 39.09 billion by 2030, rising at a CAGR of 4.61%. Growth can be attributed to the growing geriatric population and the increasing prevalence of chronic disorders amid this demographic. The rising demand for end-of-life care for chronic disorders, such as cancer, dementia, and cardiovascular disease, drives the growth of the industry. According to NHPCO statistics, in 2020, 1.72 million Medicare beneficiaries in the U.S. received hospice services for at least one day or more. Enrollment rate increased by around 6.8% from 2019.

The adoption of new technologies among providers is constantly growing. This includes bringing services to rural areas and demonstrating how technology is transforming the approach to care. Many service providers have begun to deploy technology such as telemedicine, predictive analytics, virtual reality, and artificial intelligence. For instance, in March 2023, WorldView partnered with care co-ordinations to design a solution to transform home health & hospice care delivery by integrating automation and patient engagement.

The COVID-19 pandemic negatively impacted the market by affecting long-term projections and operational goals of the industry in the U.S. providers reported the lowest share of Medicare decedents enrolled for care since 2013, owing to the death rate outpacing the increase in enrollment rate. According to NHPCO data, in 2020, around 47.8% of Medicare decedents received hospice care in the U.S., much lower than around 51.6% in 2019. Currently, these centers are adopting advanced technologies due to patients refusing in-person visits during the COVID-19 pandemic. This is expected to drive market growth post-pandemic.

U.S. Hospice Market Report Highlights

  • Based on type, Routine Homecare (RHC) segment dominated the market in 2024 and accounted for the largest revenue share of 92.98%.
  • The hospice center segment held the largest market share of 86.32% in 2024, owing to the various benefits offered by these facilities.
  • The dementia segment held the largest market share of 25.17% in 2024, owing to the dependency and disability among the elderly, with significant physical and psychological effects on individuals, their families, and caregivers.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Location Segment
1.2.3. Diagnosis Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. U.S. Hospice Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increased awareness of end-of-life care
3.2.1.2. Rising preference for home-based care
3.2.1.3. Rising geriatric population
3.2.1.4. Growing prevalence of chronic conditions
3.2.1.5. Increasing number of hospice centers
3.2.2. Market restraint analysis
3.2.2.1. Underutilization of hospice services among population
3.2.2.2. Shortage of workforce
3.2.3. Industry challenges analysis
3.2.3.1. Correct documentation
3.2.3.2. Misconceptions & late referrals
3.2.4. Industry opportunity analysis
3.2.4.1. Initiatives by hospice care centers
3.2.4.2. Adoption of new technologies
3.3. Regulatory Framework & Reimbursement Scenario
3.4. State-wise Performance Metrics in Hospice Care Delivery in the U.S.
3.5. U.S. Hospice Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.2.4. Environmental Landscape
3.5.2.5. Legal Landscape
3.5.2.6. Social Landscape
Chapter 4. U.S. Hospice Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Hospice Market Type Movement Analysis
4.3. U.S. Hospice Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Routine Home Care
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Continuous Home Care
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Inpatient Respite Care
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. General Inpatient Care
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Hospice Market: Location Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Hospice Market Location Movement Analysis
5.3. U.S. Hospice Market Size & Trend Analysis, by Location, 2018 to 2030 (USD Million)
5.4. Hospice Center
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Hospital
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Home Hospice Care
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Skilled Nursing Facility
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Hospice Market: Diagnosis Model Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Hospice Market Diagnosis Movement Analysis
6.3. U.S. Hospice Market Size & Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
6.4. Dementia
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Circulatory/Heart
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Cancer
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Respiratory
6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Stroke
6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.9. Chronic Kidney Disease
6.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.10. Others
6.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2024
7.4. Company Profiles/Listing
7.4.1. Chemed Corporation (VITAS Healthcare)
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Service benchmarking
7.4.1.4. Strategic initiatives
7.4.2. LHC Group, Inc. (UnitedHealth Group)
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Service benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Amedisys
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Service benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Gentiva
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Service benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Brookdale Senior Living, Inc
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Service benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Crossroads Hospice (Agape Care Group)
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Service benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Seasons Hospice
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Service benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Oklahoma Palliative & Hospice Care
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Service benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Compassus
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Service benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Chapters Health System
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Service benchmarking
7.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. Hospice market, by type, 2018-2030 (USD Million)
Table 3 U.S. Hospice market, by location, 2018-2030 (USD Million)
Table 4 U.S. Hospice market, by diagnosis, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Market formulation & validation
Figure 4 U.S. Hospice market: Market outlook
Figure 5 U.S. Hospice market: Segment outlook
Figure 6 U.S. Hospice market: Competitive landscape outlook
Figure 7 Parent market outlook
Figure 8 U.S. Hospice market driver impact
Figure 9 U.S. Hospice market restraint impact
Figure 10 U.S. Hospice market: Type outlook and key takeaways
Figure 11 U.S. Hospice market: Type movement analysis
Figure 12 Routine home care market estimates and forecasts, 2018-2030 (USD Million)
Figure 13 Continuous home care market estimates and forecasts, 2018-2030 (USD Million)
Figure 14 Inpatient respite care market estimates and forecasts, 2018-2030 (USD Million)
Figure 15 General inpatient care market estimates and forecasts, 2018-2030 (USD Million)
Figure 16 U.S. Hospice market: Location outlook and key takeaways
Figure 17 U.S. Hospice market: Location movement analysis
Figure 18 Hospice center market estimates and forecasts, 2018-2030 (USD Million)
Figure 19 Hospital market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Home hospice care market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Skilled nursing facility market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 U.S. Hospice market: Diagnosis outlook and key takeaways
Figure 23 U.S. Hospice market: Diagnosis movement analysis
Figure 24 Dementia market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Circulatory/heart market estimates and forecast, 2018-2030 (USD Million)
Figure 26 Cancer market estimates and forecast, 2018-2030 (USD Million)
Figure 27 Respiratory market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Stroke market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Chronic kidney disease market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Others market estimates and forecast, 2018-2030 (USD Million)

Companies Mentioned

The major companies profiled in this U.S. Hospice market report include:
  • Chemed Corporation (VITAS Healthcare)
  • LHC Group, Inc. (UnitedHealth Group)
  • Amedisys
  • Gentiva
  • Brookdale Senior Living, Inc
  • Crossroads Hospice (Agape Care Group)
  • Seasons Hospice
  • Oklahoma Palliative & Hospice Care
  • Compassus
  • Chapters Health System

Methodology

Loading
LOADING...

Table Information